James Healy's Net Worth
James Healy's net worth is estimated to be at least $110,520,190.20 as of 12/24/2024. CoreStreet's estimation of James Healy's net worth is based on their sale of stock and current holding of stock.
James Healy is Director at Rapport Therapeutics, Inc. Common Stock. They have executed at least 22 trades of stock as per SEC Form 4 filings. Their most recent trade was for 44,032 units of RAPP stock on 07/01/2024. Their biggest sale was on 07/02/2019 when they sold 360,000 units of Coherus BioSciences Inc stock for $8,028,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $77,832,240.38
Total value of insider sells:
- $32,687,949.82
Most recent insider trade:
- July 1, 2024
James Healy's Insider Trading History
| Rapport Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 1, 2024 | Director | 44,032 | $24.52 | Buy | $1,079,664.64 |
| Karuna Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 13, 2023 | Director | 6,027 | $199.90 | Sell | $1,204,797.30 |
June 29, 2022 | Director | 47,777 | $123.04 | Buy | $5,878,482.08 |
April 1, 2022 | Director | 47 | $129.38 | Buy | $6,080.86 |
July 2, 2021 | Director | 636 | $117.80 | Buy | $74,920.80 |
Sept. 8, 2020 | Director | 504 | $73.00 | Buy | $36,792.00 |
Nov. 25, 2019 | Director | 156,250 | $96.00 | Buy | $15,000,000.00 |
July 2, 2019 | Director | 700,000 | $16.00 | Buy | $11,200,000.00 |
| CinCor Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 11, 2022 | Director | 506,000 | $30.00 | Buy | $15,180,000.00 |
| Coherus BioSciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2021 | Director | 286,076 | $16.12 | Sell | $4,611,545.12 |
Sept. 27, 2021 | Director | 100,150 | $18.06 | Sell | $1,808,709.00 |
July 2, 2019 | Director | 360,000 | $22.30 | Sell | $8,028,000.00 |
June 28, 2019 | Director | 200,000 | $22.05 | Sell | $4,410,000.00 |
June 20, 2019 | Director | 317,130 | $21.37 | Sell | $6,777,068.10 |
May 22, 2019 | Director | 257,870 | $20.69 | Sell | $5,335,330.30 |
Aug. 29, 2018 | Director | 25,000 | $20.50 | Sell | $512,500.00 |
| Natera Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 22, 2021 | Director | 2,400 | $113.00 | Buy | $271,200.00 |
July 8, 2015 | Director | 350,000 | $18.00 | Buy | $6,300,000.00 |
July 2, 2015 | Director | 400,000 | $22.81 | Buy | $9,124,000.00 |
| Y mAbs Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 30, 2019 | Director | 90,000 | $29.79 | Buy | $2,681,100.00 |
Sept. 21, 2018 | Director | 500,000 | $16.00 | Buy | $8,000,000.00 |
| Humanigen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 31, 2013 | Director | 375,000 | $8.00 | Buy | $3,000,000.00 |